10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2009 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 3, 2010 10-K (Filed: Mar 1, 2010) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 3, 2010 | Dec 28, 2008 | Dec 30, 2007 | |
| Sales to customers | $ 61,897 | 63,747 | 61,095 |
| Cost of products sold | 18,447 | 18,511 | 17,751 |
| Gross profit | 43,450 | 45,236 | 43,344 |
| Selling, marketing and administrative expenses | 19,801 | 21,490 | 20,451 |
| Research expense | 6,986 | 7,577 | 7,680 |
| Purchased in-process research and development (Note 20) | 0 | 181 | 807 |
| Interest income | (90) | (361) | (452) |
| Interest expense, net of portion capitalized (Note 4) | 451 | 435 | 296 |
| Other (income) expense, net | (526) | (1,015) | 534 |
| Restructuring (Note 22) | 1,073 | 0 | 745 |
| Earnings before provision for taxes on income | 15,755 | 16,929 | 13,283 |
| Provision for taxes on income (Note 8) | 3,489 | 3,980 | 2,707 |
| Net earnings | 12,266 | 12,949 | 10,576 |
| Basic net earnings per share (Notes 1 and 15) | 4.45 | 4.62 | 3.67 |
| Diluted net earnings per share (Notes 1 and 15) | 4.40 | 4.57 | 3.63 |
| Cash dividends per share | 1.93 | 1.79 | 1.62 |
| Basic average shares outstanding (Notes 1 and 15) | 2,759,500 | 2,802,500 | 2,882,900 |
| Diluted average shares outstanding (Notes 1 and 15) | 2,789,100 | 2,835,600 | 2,910,700 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2009 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Jan 3, 2010 10-K (Filed: Mar 1, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Jan 3, 2010 | Dec 28, 2008 | Dec 30, 2007 | |
| Cash flows from operating activities | |||
| Net earnings | $ 12,266 | 12,949 | 10,576 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 2,774 | 2,832 | 2,777 |
| Stock based compensation | 628 | 627 | 698 |
| Purchased in-process research and development | 0 | 181 | 807 |
| Intangible asset write-down (NATRECOR) | 0 | 0 | 678 |
| Deferred tax provision | (436) | 22 | (1,762) |
| Accounts receivable allowances | 58 | 86 | 22 |
| Changes in assets and liabilities, net of effects from acquisitions: | |||
| Decrease/(increase) in accounts receivable | 453 | (736) | (416) |
| Decrease/(increase) in inventories | 95 | (101) | 14 |
| (Decrease)/increase in accounts payable and accrued liabilities | (507) | (272) | 2,642 |
| Decrease/(increase) in other current and non-current assets | 1,209 | (1,600) | (1,578) |
| Increase in other current and non-current liabilities | 31 | 984 | 564 |
| Net cash flows from operating activities | 16,571 | 14,972 | 15,022 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (2,365) | (3,066) | (2,942) |
| Proceeds from the disposal of assets | 154 | 785 | 457 |
| Acquisitions, net of cash acquired (Note 20) | (2,470) | (1,214) | (1,388) |
| Purchases of investments | (10,040) | (3,668) | (9,659) |
| Sales of investments | 7,232 | 3,059 | 7,988 |
| Other (primarily intangibles) | (109) | (83) | (368) |
| Net cash used by investing activities | (7,598) | (4,187) | (5,912) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (5,327) | (5,024) | (4,670) |
| Repurchase of common stock | (2,130) | (6,651) | (5,607) |
| Proceeds from short-term debt | 9,484 | 8,430 | 19,626 |
| Retirement of short-term debt | (6,791) | (7,319) | (21,691) |
| Proceeds from long-term debt | 9 | 1,638 | 5,100 |
| Retirement of long-term debt | (219) | (24) | (18) |
| Proceeds from the exercise of stock options/excess tax benefits | 882 | 1,486 | 1,562 |
| Net cash used by financing activities | (4,092) | (7,464) | (5,698) |
| Effect of exchange rate changes on cash and cash equivalents | 161 | (323) | 275 |
| Increase in cash and cash equivalents | 5,042 | 2,998 | 3,687 |
| Cash and cash equivalents, beginning of year (Note 1) | 10,768 | 7,770 | |
| Cash and cash equivalents, end of year (Note 1) | 15,810 | 10,768 | 7,770 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 533 | 525 | 314 |
| Income taxes | 2,363 | 4,068 | 4,099 |
| Supplemental schedule of noncash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds | 541 | 593 | 738 |
| Conversion of debt | 2 | 0 | 9 |
| Acquisitions | |||
| Fair value of assets acquired | 3,345 | 1,328 | 1,620 |
| Fair value of liabilities assumed and non-controlling interests | (875) | (114) | (232) |
| Net cash paid for acquisitions | 2,470 | 1,214 | 1,388 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2009 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 3, 2010 10-K (Filed: Mar 1, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Jan 3, 2010 | Dec 28, 2008 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 15,810 | 10,768 |
| Marketable securities (Notes 1 and 2) | 3,615 | 2,041 |
| Accounts receivable trade, less allowances for doubtful accounts $333 (2008,$268) | 9,646 | 9,719 |
| Inventories (Notes 1 and 3) | 5,180 | 5,052 |
| Deferred taxes on income (Note 8) | 2,793 | 3,430 |
| Prepaid expenses and other receivables | 2,497 | 3,367 |
| Total current assets | 39,541 | 34,377 |
| Property, plant and equipment, net (Notes 1 and 4) | 14,759 | 14,365 |
| Intangible assets, net (Notes 1 and 5) | 16,323 | 13,976 |
| Goodwill (Notes 1 and 5) | 14,862 | 13,719 |
| Deferred taxes on income (Note 8) | 5,507 | 5,841 |
| Other assets | 3,690 | 2,634 |
| Total assets | 94,682 | 84,912 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | 6,318 | 3,732 |
| Accounts payable | 5,541 | 7,503 |
| Accrued liabilities | 5,796 | 5,531 |
| Accrued rebates, returns and promotions | 2,028 | 2,237 |
| Accrued salaries, wages and commissions | 1,606 | 1,432 |
| Accrued taxes on income | 442 | 417 |
| Total current liabilities | 21,731 | 20,852 |
| Long-term debt (Note 7) | 8,223 | 8,120 |
| Deferred taxes on income (Note 8) | 1,424 | 1,432 |
| Employee related obligations (Notes 9 and 10) | 6,769 | 7,791 |
| Other liabilities | 5,947 | 4,206 |
| Total liabilities | 44,094 | 42,401 |
| Shareholders' equity | ||
| Preferred stock - without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock - par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (Note 13) | (3,058) | (4,955) |
| Retained earnings | 70,306 | 63,379 |
| Shareholders' equity before deduction of treasury stock | 70,368 | 61,544 |
| Less: common stock held in treasury, at cost (Note 12) (365,522,000 and 350,665,000) | 19,780 | 19,033 |
| Total shareholders' equity | 50,588 | 42,511 |
| Total liabilities and shareholders' equity | 94,682 | 84,912 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |